Quantcast

Contract Research Organization WCCT Global Announces Allocation of New Ophthalmology Research Site Located Near California Based Clinical Pharmacology Units to Expand Ophthalmology Research Capabilities

September 20, 2013

WCCT Global strategically acquires ophthalmology research site near Southern California-based clinical pharmacology units.

Costa Mesa, CA (PRWEB) September 20, 2013

WCCT Global, a Southern California headquartered, full service CRO, announces today that they can now provide expanded research support in ophthalmic medicine and science. These new ophthalmic research services are in addition to the diverse clinical services our sponsors have enjoyed for several years. This acquisition of OC Clinical Trials & Consulting will provide research capabilities spanning glaucoma, oculoplastics, cosmetic clinical research, cornea & external ocular disease, and pediatric ophthalmic conditions at 2 sites in Tustin, CA. This acquisition supports WCCT Global’s vision to offer innovative service options to their clients in the form of designated research and patient care specialty facilities for both early and late phase clinical research spanning multiple specialty therapeutic areas. This new ophthalmology research facility is also in close proximity to WCCT Global’s multiple Southern California based clinical pharmacology units located in Orange County, CA. Having the 5 clinical research facilities within minutes of each other provides sponsors the ability and convenience of visiting each location during any single visit to California. WCCT Global’s Chief Operating Officer Jon Rojas stated, “The strategic placement of each of our 5 California research facilities offering unique therapeutic research services enables WCCT Global to provide both patient access and expert therapeutic knowledge and experience for each clinical study that we carry out on behalf of our Sponsors.”

About WCCT Global:

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow’s therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you are interested in visiting one of our Clinical Pharmacology Units, click here and request a time to come visit.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11142535.htm


Source: prweb



comments powered by Disqus